A randomized phase II study of estramustine phosphate versus estramustine phosphate plus etoposide in hormone refractory prostate cancer (HRPC).
- Autori: F Fulfaro, V Serretta, G Cicero, G Morgia, V Altieri, A Siragusa, M Falsaperla, M Napoli, G De Grande, D Melloni
- Anno di pubblicazione: 2008
- Tipologia: eedings
- Parole Chiave: prostate cancer, chemotherapy, efficacy
- OA Link: http://hdl.handle.net/10447/44510